In accordance with the Ministry of Food and Drug Safety's 'Drug Approval Change Order' (Drug Policy Division-No. 3890, effective date August 22, 2013), the precautions for use of Diropine Long-Lasting Tablets and Diropine Long-Lasting Tablets 2.5 mg have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Diropine long-acting tablet, Diropine long-acting tablet 2.5mg
Attachments are original documents and may be in Korean. English editions are labeled separately.
Felodipine single agent (oral) unification adjustment (draft).hwpFelodipine single agent (oral) unification adjustment (draft).hwp · 38 KBDownload ↓